JP2012521377A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012521377A5 JP2012521377A5 JP2012501179A JP2012501179A JP2012521377A5 JP 2012521377 A5 JP2012521377 A5 JP 2012521377A5 JP 2012501179 A JP2012501179 A JP 2012501179A JP 2012501179 A JP2012501179 A JP 2012501179A JP 2012521377 A5 JP2012521377 A5 JP 2012521377A5
- Authority
- JP
- Japan
- Prior art keywords
- mmol
- mixture
- azaspiro
- pyridin
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- BQGSQOJLJNORRH-AWEZNQCLSA-N (3s)-3-[(2-chlorobenzoyl)amino]-2,3-dihydro-1h-indene-4-carboxylic acid Chemical compound N([C@H]1CCC=2C=CC=C(C1=2)C(=O)O)C(=O)C1=CC=CC=C1Cl BQGSQOJLJNORRH-AWEZNQCLSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- YPDBTGIIQHAPMI-UHFFFAOYSA-N 2-azaspiro[4.5]decan-8-ol Chemical compound C1NCCC11CCC(CC1)O YPDBTGIIQHAPMI-UHFFFAOYSA-N 0.000 description 1
- -1 2-benzyl-8- (pyridin-4-yl) -2-azaspiro [4.5] dec-7-ene pyridine Chemical compound 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- REYMPXXKOPTETK-UHFFFAOYSA-N 8-pyridin-4-yl-2-azaspiro[4.5]decane Chemical compound C1NCCC21CCC(C=1C=CN=CC=1)CC2 REYMPXXKOPTETK-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 1
- 241001274216 Naso Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09004235 | 2009-03-25 | ||
| EP09004235.9 | 2009-03-25 | ||
| EP09011708 | 2009-09-14 | ||
| EP09011708.6 | 2009-09-14 | ||
| PCT/EP2010/001804 WO2010108651A1 (en) | 2009-03-25 | 2010-03-23 | Substituted spiro-amide compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012521377A JP2012521377A (ja) | 2012-09-13 |
| JP2012521377A5 true JP2012521377A5 (enExample) | 2013-02-14 |
Family
ID=42224836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012501179A Pending JP2012521377A (ja) | 2009-03-25 | 2010-03-23 | 置換スピロアミド化合物 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US8455475B2 (enExample) |
| EP (1) | EP2411381A1 (enExample) |
| JP (1) | JP2012521377A (enExample) |
| KR (1) | KR20110137377A (enExample) |
| CN (1) | CN102365276A (enExample) |
| AR (1) | AR076148A1 (enExample) |
| AU (1) | AU2010227802A1 (enExample) |
| BR (1) | BRPI1013614A2 (enExample) |
| CA (1) | CA2756532A1 (enExample) |
| CO (1) | CO6430424A2 (enExample) |
| EC (1) | ECSP11011390A (enExample) |
| IL (1) | IL215267A0 (enExample) |
| MX (1) | MX2011010068A (enExample) |
| NZ (1) | NZ595293A (enExample) |
| PE (1) | PE20120833A1 (enExample) |
| RU (1) | RU2011142618A (enExample) |
| TW (1) | TW201038572A (enExample) |
| WO (1) | WO2010108651A1 (enExample) |
| ZA (1) | ZA201107772B (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2623101B1 (en) * | 2009-04-02 | 2021-04-21 | Merck Patent GmbH | Piperidine and piperazine derivatives as autotaxin inhibitors |
| PL2547679T3 (pl) * | 2010-03-19 | 2016-02-29 | Pfizer | Pochodne 2,3-dihydro-1H-inden-1-ylo-2,7-diazaspiro[3.5]nonanu i ich zastosowanie jako antagonistów lub odwrotnych agonistów receptora greliny |
| US8809552B2 (en) * | 2011-11-01 | 2014-08-19 | Hoffmann-La Roche Inc. | Azetidine compounds, compositions and methods of use |
| TWI633087B (zh) * | 2012-06-13 | 2018-08-21 | 赫孚孟拉羅股份公司 | 新穎二氮雜螺環烷及氮雜螺環烷 |
| EP3590940B1 (en) | 2012-09-25 | 2021-06-09 | F. Hoffmann-La Roche AG | Hexahydropyrrolo[3,4-c]pyrrole derivatives and related compounds as autotaxin (atx) inhibitors and as inhibitors of the lysophosphatidic acid (lpa) production for treating e.g. renal diseases |
| AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
| KR102323515B1 (ko) | 2013-09-12 | 2021-11-05 | 얀센 바이오파마, 인코퍼레이트. | 아자-피리돈 화합물 및 이의 용도 |
| NO3074400T3 (enExample) | 2013-11-26 | 2018-04-14 | ||
| EP3122751B1 (en) | 2014-03-26 | 2019-10-30 | F.Hoffmann-La Roche Ag | Condensed [1,4]diazepine compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors |
| MA39792B1 (fr) | 2014-03-26 | 2019-12-31 | Hoffmann La Roche | Composés bicycliques en tant qu'inhibiteurs de production d'autotaxine (atx) et d'acide lysophosphatidique (lpa) |
| EA201790185A1 (ru) * | 2014-07-15 | 2017-07-31 | Грюненталь Гмбх | Замещенные азаспиро(4.5)декановые производные |
| EA036776B1 (ru) | 2015-03-11 | 2020-12-21 | Янссен Байофарма, Инк. | Соединения азапиридона и способы их применения |
| CN106008503B (zh) * | 2015-03-31 | 2020-09-01 | 齐鲁制药有限公司 | 螺环芳基砜作为蛋白激酶抑制剂 |
| MA41898A (fr) | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | Dérivés de quinazolinone bicyclique |
| MX387736B (es) | 2015-09-04 | 2025-03-18 | Hoffmann La Roche | Derivados de fenoximetilo. |
| KR20180054634A (ko) | 2015-09-24 | 2018-05-24 | 에프. 호프만-라 로슈 아게 | 이중 오토탁신(atx)/탄산 무수화효소(ca) 억제제로서 신규한 이환형 화합물 |
| PE20180451A1 (es) | 2015-09-24 | 2018-03-05 | Hoffmann La Roche | Nuevos compuestos biciclicos como inhibidores de atx |
| CN107635995B (zh) | 2015-09-24 | 2022-08-19 | 豪夫迈·罗氏有限公司 | 作为atx抑制剂的二环化合物 |
| MX2017015034A (es) | 2015-09-24 | 2018-04-13 | Hoffmann La Roche | Nuevos compuestos biciclicos como inhibidores duales de autotaxina (atx)/anhidrasa carbonica (ca). |
| US9988390B2 (en) | 2015-10-30 | 2018-06-05 | F. Hoffmann-La Roche Ag | Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| CN108779116A (zh) * | 2015-12-22 | 2018-11-09 | 生命医药公司 | 多发性内分泌瘤蛋白-mll相互作用的抑制剂 |
| DK3402785T3 (da) | 2016-01-13 | 2020-04-20 | Gruenenthal Gmbh | 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decan-derivater |
| AU2017206908B2 (en) | 2016-01-13 | 2020-07-09 | Grünenthal GmbH | 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives |
| MX379359B (es) | 2016-01-13 | 2025-03-11 | Gruenenthal Gmbh | Derivados de 8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano. |
| EP3429591B1 (en) | 2016-03-16 | 2023-03-15 | Kura Oncology, Inc. | Substituted thieno[2,3-d]pyrimidine derivatives as inhibitors of menin-mll and methods of use |
| CA3032136A1 (en) | 2016-07-28 | 2018-02-01 | Mayo Foundation For Medical Education And Research | Small molecule activators of parkin enzyme function |
| EP3366683A1 (en) * | 2017-02-28 | 2018-08-29 | Acousia Therapeutics GmbH | Cyclic amides, acteamides and ureas useful as potassium channel openers |
| CN110382484B (zh) | 2017-03-16 | 2022-12-06 | 豪夫迈·罗氏有限公司 | 新的作为atx抑制剂的二环化合物 |
| MA49879A (fr) | 2017-03-16 | 2020-06-24 | Hoffmann La Roche | Composés hétérocycliques utiles en tant qu'inhibiteurs doubles d'atx/ca |
| TW201920170A (zh) | 2017-09-20 | 2019-06-01 | 美商庫拉腫瘤技術股份有限公司 | 經取代之menin-mll 抑制劑及使用方法 |
| WO2019200114A1 (en) * | 2018-04-12 | 2019-10-17 | Arbutus Biopharma Corporation | Methods for preparing substituted dihydroindene-4-carboxamide compounds |
| CN111434664A (zh) * | 2019-01-13 | 2020-07-21 | 西南大学 | 亚胺螺环哌啶类化合物的合成及应用 |
| WO2022165513A1 (en) | 2021-01-29 | 2022-08-04 | Cedilla Therapeutics, Inc. | Cdk2 inhibitors and methods of using the same |
| CA3225439A1 (en) | 2021-06-26 | 2022-12-29 | Cedilla Therapeutics, Inc. | Cdk2 inhibitors and methods of using the same |
| CN113976072B (zh) * | 2021-11-10 | 2024-02-23 | 武汉青风凯默生物医药科技有限公司 | 一种4-甲酰基-n-cbz哌啶的制备装置及方法 |
| EP4530282A4 (en) | 2022-04-28 | 2026-05-06 | Sds Biotech Corp | ANILIDE HALOALKYLSULPHONE COMPOUND AND HERBICIDE THE CONTAINER |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2341678C (en) * | 1998-09-01 | 2009-10-13 | Bristol-Myers Squibb Company | Potassium channel inhibitors and method |
| US6686370B2 (en) * | 1999-12-06 | 2004-02-03 | Euro-Celtique S.A. | Triazospiro compounds having nociceptin receptor affinity |
| WO2005087236A1 (en) | 2004-03-11 | 2005-09-22 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
| CA2560691A1 (en) | 2004-03-24 | 2005-10-13 | Abbott Laboratories | Tricyclic pyrazole kinase inhibitors |
| EP1802577A1 (en) * | 2004-10-15 | 2007-07-04 | Bayer Pharmaceuticals Corporation | Indane amides with antiproliferative activity |
| MX2007005820A (es) * | 2004-11-18 | 2007-07-18 | Incyte Corp | Inhibidores de deshidrogenasa esteroide hidroxilo 11-beta tipo 1 y metodos de uso de los mismos. |
| JP2008537953A (ja) * | 2005-04-15 | 2008-10-02 | エラン ファーマシューティカルズ，インコーポレイテッド | ブラジキニンｂ１受容体拮抗作用に有用な新規化合物 |
| DE102005030051A1 (de) * | 2005-06-27 | 2006-12-28 | Grünenthal GmbH | Substituierte 1-Oxa-3,8-diazaspiro[4,5]-decan-2-on-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln |
| KR20080036041A (ko) * | 2005-07-19 | 2008-04-24 | 머크 앤드 캄파니 인코포레이티드 | 아세틸 조효소 카복실라제(ａｃｃ) 억제제로서의스피로크로마논 유도체 |
| WO2007101007A2 (en) | 2006-02-23 | 2007-09-07 | Neurogen Corporation | Aryl sulfonyl heterocycles |
| WO2007140383A2 (en) | 2006-05-30 | 2007-12-06 | Neurogen Corporation | Spirocyclic sulfonamides and related compounds |
| MX2009003382A (es) | 2006-09-29 | 2009-04-08 | Gruenenthal Gmbh | Derivados de sulfonamidas sustituidos. |
| EP2086935A1 (de) | 2006-10-16 | 2009-08-12 | Grünenthal GmbH | Substituierte sulfonamid-derivate als bradykinin 1 rezeptor modulatoren |
-
2010
- 2010-03-19 TW TW099108105A patent/TW201038572A/zh unknown
- 2010-03-23 WO PCT/EP2010/001804 patent/WO2010108651A1/en not_active Ceased
- 2010-03-23 CN CN2010800139828A patent/CN102365276A/zh active Pending
- 2010-03-23 KR KR1020117025143A patent/KR20110137377A/ko not_active Withdrawn
- 2010-03-23 EP EP10711343A patent/EP2411381A1/en not_active Withdrawn
- 2010-03-23 AU AU2010227802A patent/AU2010227802A1/en not_active Abandoned
- 2010-03-23 MX MX2011010068A patent/MX2011010068A/es active IP Right Grant
- 2010-03-23 BR BRPI1013614A patent/BRPI1013614A2/pt not_active IP Right Cessation
- 2010-03-23 JP JP2012501179A patent/JP2012521377A/ja active Pending
- 2010-03-23 NZ NZ595293A patent/NZ595293A/xx not_active IP Right Cessation
- 2010-03-23 RU RU2011142618/04A patent/RU2011142618A/ru not_active Application Discontinuation
- 2010-03-23 PE PE2011001692A patent/PE20120833A1/es not_active Application Discontinuation
- 2010-03-23 CA CA2756532A patent/CA2756532A1/en not_active Abandoned
- 2010-03-24 US US12/730,597 patent/US8455475B2/en not_active Expired - Fee Related
- 2010-03-25 AR ARP100100948A patent/AR076148A1/es not_active Application Discontinuation
-
2011
- 2011-09-21 IL IL215267A patent/IL215267A0/en unknown
- 2011-09-22 CO CO11123935A patent/CO6430424A2/es not_active Application Discontinuation
- 2011-10-11 EC ECSP11011390 patent/ECSP11011390A/es unknown
- 2011-10-24 ZA ZA2011/07772A patent/ZA201107772B/en unknown
-
2013
- 2013-04-15 US US13/862,690 patent/US20130231327A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103582622B (zh) | 经由亚胺鎓盐制备双环化合物的方法 | |
| JP6574474B2 (ja) | キラルジペプチジルペプチダーゼ−ｉｖ阻害剤の製造方法 | |
| WO2021056811A1 (zh) | 亚胺盐衍生物、其制备方法及尼古丁的制备方法 | |
| AU2015229742A1 (en) | Clomiphene synthesis using a single solvent | |
| JP2016500657A5 (enExample) | ||
| CN105198808A (zh) | 一种高效生产贝达喹啉的方法 | |
| CN102675181B (zh) | 一种左乙拉西坦的制备方法 | |
| JP5485138B2 (ja) | エチニルチミジン化合物の精製方法 | |
| CN107540604A (zh) | 一种2‑氨基‑5‑溴吡啶的制备方法 | |
| CN105037216A (zh) | 一种月桂酰精氨酸盐酸盐的制备方法 | |
| CN103288650B (zh) | 一种盐酸1-氨基-3,5-二甲基金刚烷的制备方法 | |
| CN113121318B (zh) | 一种联/杂芳烃类化合物及其制备方法 | |
| CN104710346A (zh) | 一种合成顺式-1-苄基-3-甲氨基-4-甲基-哌啶的方法 | |
| CN109232562A (zh) | 一种7-氮杂吲哚-5-氯-6-羧酸的合成方法 | |
| CN106045995A (zh) | 一种5‑溴‑1H‑吡咯并[2,3‑b]吡啶的合成方法 | |
| JP2020515553A (ja) | １−（４−メタンスルホニル−２−トリフルオロメチル−ベンジル）−２−メチル−１Ｈ−ピロロ［２，３−ｂ］ピリジン−３−イル−酢酸を調製するためのプロセス | |
| CN102633779A (zh) | 法舒地尔乙酸盐及其制备方法和应用 | |
| CN101747343B (zh) | 一种舒巴坦匹酯的制备方法 | |
| TWI361807B (en) | Process for preparing substituted 4-alkoxycarbonyl-3-aminothiophenes | |
| CN104961674B (zh) | 用于合成依托考昔的对照品的制备方法 | |
| CN104311495B (zh) | 一种nh‑1,2,3‑三氮唑的合成方法 | |
| CN103588600A (zh) | 一种空气氛围中铜催化有机硼酸化合物脱除硼酸基的方法 | |
| CN105315288A (zh) | 一种制备四氢吡咯并吡嗪并异吲哚衍生物的方法 | |
| CN104592178B (zh) | 一种脱氢枞酸内酯的制备方法 | |
| CN110105361B (zh) | 一种Evodiakine及其衍生物的制备方法 |